Moreover, the inhibition of NFκB activity sensitizes resistant colon cancer cells through a decreased ABCB1 expression, providing a link between NFκB and resistance to chemotherapy through the regulation of human ABCB1 gene expression [198]. The gene discussed is NFKB1; the disease is colonic neoplasm.